Leukemia Researcher Featured in Live Internet Chat
02/14/00 Portland, Ore.
Brian Druker will discuss breakthrough leukemia pill featured on ABC's 20/20
Unlike chemotherapy, which kills both normal and abnormal cells as a way of eliminating cancer, the compound STI-571 targets an enzyme found only in the leukemia cells. In phase one testing, Druker tested 31 patients at the effective dose and all 31 had their blood counts return to normal. In four patients, all signs of the molecular abnormality causing the disease have disappeared.
Druker was featured in an in-depth story on ABC's newsmagazine 20/20 this past Friday, Feb. 11. The story focused on Druker's career, how he developed the drug and the lives of several patients who have been taking the drug in clinical trials.